Valuation Unichem Laboratories Limited

Stocks

Market Closed - Bombay S.E. 14:02:22 16/10/2026 +04			5-day change	1st Jan Change
510.35 ^INR	-1.87%		-3.54%	+15.63%

08-11	Unichem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-23	Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	21,776	18,330	20,351	34,393	48,777	20,682
Change	-	-15.83%	11.02%	69%	41.82%	-57.6%
Enterprise Value (EV) ¹	19,829	18,094	21,638	35,346	52,479	22,788
Change	-	-8.75%	19.59%	63.35%	48.47%	-56.58%
P/E	63.4x	55.6x	-10.1x	-48.8x	35.6x	8.19x
PBR	0.85x	0.7x	0.84x	1.46x	1.99x	0.76x
PEG	-	-13.88x	0x	0.7x	-0x	0.1x
Capitalization / Revenue	1.76x	1.44x	1.52x	2.02x	2.31x	0.94x
EV / Revenue	1.61x	1.42x	1.61x	2.07x	2.49x	1.03x
EV / EBITDA	23.6x	24.2x	-45.1x	37.5x	20.4x	12.6x
EV / EBIT	273x	-166x	-13.9x	-272x	37.4x	35.8x
EV / FCF	-9.72x	-5.18x	-29.2x	64.1x	-23.3x	-20.8x
FCF Yield	-10.3%	-19.3%	-3.42%	1.56%	-4.3%	-4.8%
Dividend per Share ²	4	4	-	-	-	-
Rate of return	1.29%	1.54%	-	-	-	-
EPS ²	4.875	4.68	-28.72	-10.01	19.47	35.85
Distribution rate	82%	85.5%	-	-	-	-
Net sales ¹	12,351	12,698	13,430	17,049	21,110	22,018
EBITDA ¹	838.6	747	-480.2	943.7	2,577	1,815
EBIT ¹	72.76	-109	-1,556	-129.9	1,403	635.7
Net income ¹	343.2	330.6	-2,022	-704.7	1,375	2,528
Net Debt ¹	-1,948	-236.2	1,288	952.6	3,702	2,107
Reference price ²	309.30	260.35	289.05	488.50	692.80	293.75
Nbr of stocks (in thousands)	70,406	70,406	70,406	70,406	70,406	70,406
Announcement Date	02/07/21	12/07/22	30/08/23	11/07/24	04/07/25	03/07/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
UNICHEM LABORATORIES LIMITED	-	-	-	-	387M
ELI LILLY AND COMPANY	35.8x	12.9x	27.02x	0.55%	1,116B
JOHNSON & JOHNSON	37.07x	6.25x	17.38x	2.11%	610B
ABBVIE INC.	36.17x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	112.15x	5.92x	25.35x	2.35%	358B
ROCHE HOLDING AG	20.49x	5x	12.4x	2.64%	366B
NOVARTIS AG	21.24x	5.55x	13.66x	2.88%	288B
ASTRAZENECA PLC	22x	4.43x	12.71x	1.99%	261B
AMGEN INC.	27.56x	7.08x	12.68x	2.32%	235B
GILEAD SCIENCES, INC.	-45.98x	7.04x	27.26x	2.1%	195B
Average	29.61x	6.94x	18.40x	2.15%	393.02B
Weighted average by Cap.	35.04x	8.17x	19.98x	1.84%